Date: May 30, 2014 Author: Ben Miller - Contributing Editor- Puget Sound Business Journal Source: bizjournals (
click here to go to the source)
Cell Therapeutics Inc. said it's changed its name to CTI BioPharma Corp. The change, according to CEO Dr. James Bianco, is being made because it "better reflects who we are today and our aspirations for becoming a leader in developing therapies for patients with blood-related cancers."
"From the beginning, CTI has looked at potential therapies from the patient's perspective to address both the clinical need and the impact treatment can have on a patient's life," Bianco said in a statement.
The Seattle company's NASDAQ stock symbol, "CTIC," won't change.
